In particular, follicular adenoma and minimally invasive follicular carcinoma very frequently overexpressed cdc25B, 63.2% (12 of the 19 cases) and 73.1% (19 of the 26 cases), respectively. This evidence concerns the gene CDC25B and follicular thyroid adenoma.